Zions Bancorporation National Association UT Buys New Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Key Points

• Zions Bancorporation National Association UT has acquired a new stake in Acadia Healthcare, purchasing 16,191 shares valued at approximately $491,000 in the first quarter.
• Shares of Acadia Healthcare have experienced a 12-month fluctuation, with a low of $17.13 and a high of $82.40; the stock opened at $19.24 recently.
• Acadia Healthcare recently reported earnings, achieving $0.83 EPS, surpassing analysts' expectations of $0.71, and a revenue of $869.23 million, representing a 9.2% year-over-year increase.

Zions Bancorporation National Association UT bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 16,191 shares of the company's stock, valued at approximately $491,000.

Several other large investors have also recently made changes to their positions in the business. GAMMA Investing LLC raised its holdings in Acadia Healthcare by 143.8% in the 1st quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock worth $176,000 after acquiring an additional 3,428 shares during the last quarter. Envestnet Portfolio Solutions Inc. purchased a new position in Acadia Healthcare in the 1st quarter worth approximately $222,000. Sterling Capital Management LLC raised its holdings in Acadia Healthcare by 59.1% in the 4th quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock worth $216,000 after acquiring an additional 2,026 shares during the last quarter. Raiffeisen Bank International AG raised its holdings in Acadia Healthcare by 33.3% in the 1st quarter. Raiffeisen Bank International AG now owns 160,000 shares of the company's stock worth $4,819,000 after acquiring an additional 40,000 shares during the last quarter. Finally, Teacher Retirement System of Texas purchased a new position in Acadia Healthcare in the 1st quarter worth approximately $412,000.

Acadia Healthcare Stock Performance

Shares of ACHC stock traded up $0.16 during mid-day trading on Friday, reaching $20.82. 482,426 shares of the company's stock traded hands, compared to its average volume of 2,200,308. Acadia Healthcare Company, Inc. has a 12 month low of $17.13 and a 12 month high of $82.40. The firm has a 50 day moving average price of $22.01 and a two-hundred day moving average price of $27.21. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The firm has a market capitalization of $1.92 billion, a PE ratio of 13.78, a price-to-earnings-growth ratio of 4.04 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. During the same quarter in the previous year, the firm posted $0.91 EPS. The company's revenue for the quarter was up 9.2% compared to the same quarter last year. On average, research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Ratings Changes

ACHC has been the subject of a number of recent analyst reports. Royal Bank Of Canada set a $28.00 price objective on shares of Acadia Healthcare and gave the stock an "outperform" rating in a report on Wednesday. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. Guggenheim cut their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Mizuho set a $22.00 target price on shares of Acadia Healthcare and gave the stock a "neutral" rating in a research report on Wednesday. Finally, Cowen reaffirmed a "buy" rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Five research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $40.77.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.